Menopause, Blood Pressure and Cholesterol: Why Heart Risk Changes After 50

A woman in her early fifties sits in a pharmacy chair, rolls up a sleeve and watches the cuff squeeze. The number on the screen is higher than it was two years ago. Nothing else has changed, she thinks, except that her periods stopped. As of early 2026, that scene is playing out more often, and more women are typing “menopause and blood pressure” into a search bar afterward.

Two things pushed the topic into the spotlight. In August 2025 the American Heart Association and American College of Cardiology released their first full high blood pressure guideline in eight years, keeping the stricter 130/80 threshold and leaning harder on home monitoring and a new risk calculator. A few months later, a wave of social media posts began promising that a single hormone, breathing trick or supplement could reverse midlife heart risk in a week.

The honest story sits between the clinic and the viral clip. Menopause is not a disease of the heart, yet the transition is a genuine turning point for the arteries, and the evidence on why is clearer than the headlines suggest.

How are menopause and blood pressure connected?

Menopause is the point twelve months after a woman’s last menstrual period, and in the United States it arrives at a median age of about 51. The years leading up to it, called perimenopause, are when the ovaries produce estrogen erratically and then at steadily lower levels. Blood pressure is simply the force of blood against artery walls, written as two numbers: the systolic pressure when the heart contracts and the diastolic pressure between beats.

Before age 45, more men than women have high blood pressure. The curves cross in the decade after 50, and by the late sixties women lead. That crossover is one of the most consistent findings in population data, and it is why the American Heart Association devoted a 2020 scientific statement to the menopause transition as a window of accelerating cardiovascular risk.

Why does the shift happen? Estrogen helps the inner lining of blood vessels release nitric oxide, a gas that lets arteries relax. It also dampens a hormone system called the renin-angiotensin-aldosterone system, which tells the kidneys to hold onto salt and water. When estrogen falls, arteries become a little stiffer, the kidneys retain a little more sodium, and the sympathetic nervous system, the body’s accelerator pedal, runs a little hotter. None of these changes is dramatic alone. Added to a decade of ordinary aging, they move the needle.

The practical point matters more than the physiology. A reading that was comfortably normal at 42 deserves a second look at 52, not because menopause is dangerous, but because the margin that once protected women has quietly narrowed.

What changed recently

The 2025 AHA/ACC guideline on high blood pressure, published in August 2025, is the first comprehensive update since 2017. Several of its decisions speak directly to women in midlife.

The definition of high blood pressure stayed at 130/80 mmHg or above. Some observers had expected a retreat toward the older 140/90 cut-off; the writing committee kept the lower threshold because trials since 2017 continued to show fewer strokes and heart attacks when pressure is treated toward 130/80.

The guideline swapped its risk calculator for the AHA’s PREVENT equations, which estimate ten-year risk of heart disease, stroke and heart failure using kidney function and, optionally, blood sugar markers. For a woman with stage 1 high blood pressure (130 to 139 over 80 to 89), the recommendation is three to six months of lifestyle change first; if her PREVENT ten-year risk is 7.5 percent or higher, or if lifestyle alone does not bring the numbers down, medication is advised.

Home monitoring moved from “helpful” to central. The guideline asks clinicians to confirm diagnoses with readings taken outside the office, which catches both white-coat hypertension (high only in the clinic) and masked hypertension (normal in the clinic, high at home). It also tightened advice on alcohol, suggesting that abstaining is ideal and that women who do drink keep to one drink a day at most.

Separately, in late 2025 US regulators revised the prominent boxed warnings on menopausal hormone therapy labels, a change that revived public questions about hormones and heart risk. The underlying trial data did not change, and the clinical advice remains that hormone therapy is prescribed for menopausal symptoms, not to protect the heart. That decision still belongs to a woman and her prescribing clinician.

What is a normal blood pressure for a woman in her 50s?

The same categories apply to a woman at 55 as to anyone else; age and sex do not earn a higher allowance. The American Heart Association defines the ranges below, and the 2025 guideline links each one to a next step.

Category	Systolic (top)	Diastolic (bottom)	What the 2025 guideline suggests
Normal	Below 120	and below 80	Recheck at least yearly; keep heart-healthy habits
Elevated	120–129	and below 80	Lifestyle changes; recheck in 3–6 months
Stage 1 high blood pressure	130–139	or 80–89	Lifestyle first; medication if ten-year risk is 7.5% or higher or pressure stays up
Stage 2 high blood pressure	140 or higher	or 90 or higher	Lifestyle plus medication, usually two drugs, chosen by a clinician
Hypertensive crisis	Above 180	and/or above 120	Recheck in 5 minutes; seek emergency care if still high or if symptoms are present

Two details trip people up. First, a diagnosis never rests on one reading. Blood pressure swings with caffeine, a full bladder, a rushed walk from the parking lot and the simple anxiety of being measured. Clinicians average several readings across different days. Second, the categories are set by the higher of the two numbers, so 118 over 86 counts as stage 1, not normal.

For women in their fifties the systolic number tends to be the one that creeps. Arteries stiffen with age, which pushes the top number up while the bottom number can stay flat or even fall. A widening gap between the two is itself a marker of stiffer vessels, and another reason the fifties are the decade to start paying attention.

Why does estrogen matter so much for blood vessels?

Think of an artery as a garden hose with a living lining. The inner layer, the endothelium, is a single sheet of cells that senses blood flow and decides, moment to moment, how wide the hose should be. Estrogen is one of its favorite signals.

Through receptors on those cells, estrogen boosts production of nitric oxide, which relaxes the muscle in the artery wall. It also tempers the production of endothelin, a potent constricting molecule, and quiets inflammation in the wall. Laboratory and animal studies show these effects clearly; human studies using ultrasound of the arm artery show that women lose some of their flow-mediated dilation, the artery’s ability to widen on demand, across the menopause transition.

Estrogen reaches the kidneys too. It lowers the activity of the renin-angiotensin-aldosterone system, a cascade that raises pressure by constricting vessels and retaining sodium. Several of the most widely prescribed blood pressure medicines work by blocking this exact pathway, which hints at how important the system is once estrogen’s brake is released.

A third route runs through the nervous system. Studies measuring nerve traffic to blood vessels find that sympathetic activity, the body’s fight-or-flight tone, climbs in postmenopausal women compared with premenopausal women of similar age. Higher tone means more constriction at rest and a stronger pressure response to stress.

None of this means a woman becomes hypertensive the week estrogen falls. The changes are measured in a few millimeters of mercury and a few percentage points of artery function. Stacked on top of a sedentary job, more salt than the body needs and a parent who had a stroke at 60, those small shifts become the difference between normal and stage 1.

Does menopause cause high blood pressure, or is it just getting older?

This is the question researchers have argued over for decades, and the fair answer is: both, and it is hard to separate them cleanly.

Age is the stronger force. Systolic pressure rises steadily from the twenties onward in both sexes because elastic fibers in the large arteries fray and are replaced with stiffer collagen. Any woman passing through her fifties would see some upward drift regardless of her hormones.

What the Study of Women’s Health Across the Nation (SWAN) and similar cohorts added was timing. When researchers lined women up by years since their final menstrual period rather than by birthday, certain risk factors showed a step change clustered around that point. LDL cholesterol was the clearest example. Blood pressure was murkier: some analyses found an independent menopause effect of a few mmHg after adjusting for age and weight, others found that age and body-mass index explained nearly all of the rise.

The 2020 AHA scientific statement concluded that the menopause transition is associated with adverse changes in blood pressure and that the effect is probably modest and intertwined with aging, weight gain and sleep disruption. That is a careful sentence, and it deserves to be read carefully. It does not say menopause is harmless to the arteries, and it does not say estrogen loss is the main driver of midlife hypertension.

Why does the distinction matter for a reader? Because it points the response in the right direction. If the rise were purely hormonal, replacing the hormone would be the fix, and trials show it is not. If the rise is mostly age plus lifestyle plus a hormonal nudge, then the levers that work at any age, movement, sodium, sleep, alcohol, weight and, where needed, medication, are the ones that work now.

Menopause and cholesterol: why LDL climbs around the final period

Cholesterol is a waxy substance carried through the blood in protein packages. LDL, or low-density lipoprotein, delivers cholesterol to tissues and, when there is too much, into artery walls; HDL, or high-density lipoprotein, carries it back to the liver. Of all the heart risk factors that change at menopause, LDL shows the sharpest and best-documented jump.

In SWAN, total cholesterol, LDL and apolipoprotein B (the protein count of harmful particles) rose across the transition, and the increase was concentrated in the roughly two-year window straddling the final menstrual period rather than spreading evenly over a decade. The LDL rise in that window was on the order of 10 percent, a shift that aging alone does not produce in men of the same age.

The mechanism is reasonably well understood. Estrogen increases the number of LDL receptors on liver cells, which pull LDL out of the circulation. Less estrogen means fewer receptors and more LDL left in the blood. Estrogen also influences how the liver handles triglycerides, the other fat in a standard lipid panel.

HDL tells a more complicated story. The HDL number often holds steady or even rises slightly after menopause, which once reassured clinicians. Newer work suggests the particles change character and may become less efficient at clearing cholesterol, so a stable HDL number is not the protection it appears to be.

For a woman with normal cholesterol in her forties, these changes can nudge LDL from a comfortable zone into one where a clinician starts a conversation. Mainstream guidance calls for a fasting or non-fasting lipid panel every four to six years in adults at average risk, with more frequent checks after menopause, if there is a family history, or if a result has already been borderline. The year after periods stop is a sensible time to ask for one.

Why does fat move to the waist after 50, and why does it matter?

Many women notice that their weight on the scale barely moves through the transition, yet their waistband does. Midlife weight gain averages about a pound and a half a year and tracks mostly with age and activity. What menopause changes is where the fat goes.

Before menopause, estrogen favors fat storage on the hips and thighs. As estrogen falls, storage shifts toward the abdomen and, more importantly, toward visceral fat, the kind packed around the liver and intestines. Imaging studies in SWAN found visceral fat increasing across the transition even in women whose total weight was stable.

Visceral fat is not inert padding. It releases fatty acids and inflammatory signals into the portal vein that feeds the liver, nudging the liver to produce more triglycerides and more LDL and to become less responsive to insulin. Insulin resistance in turn raises blood pressure by encouraging the kidneys to retain sodium and by stiffening small vessels. This is the midlife cluster clinicians call metabolic syndrome: a larger waist, higher triglycerides, lower HDL, higher blood pressure and higher fasting blood sugar, with any three earning the label.

A waist circumference above about 35 inches in women is the threshold most guidelines use for increased risk. It is a crude measure, but it correlates with visceral fat far better than weight alone and costs nothing but a tape measure.

The encouraging part of this story is how responsive visceral fat is. It is metabolically active in both directions, and it tends to shrink first when a woman adds brisk walking or resistance training and trims refined carbohydrates. The 2025 guideline cites a weight loss of about five percent as enough to produce a measurable drop in blood pressure, which for most women means a change of a single dress size, not a transformation.

Are hot flashes and night sweats a heart warning sign?

Hot flashes, the sudden rush of heat and sweating that most women experience during the transition, were long dismissed as a nuisance with no bearing on health. Research over the past decade has complicated that view.

In SWAN and several other cohorts, women who reported frequent hot flashes, roughly six or more a day, or whose flashes persisted for many years, had higher rates of subclinical arterial changes: thicker carotid artery walls on ultrasound and poorer flow-mediated dilation. One long-term analysis found that frequent flashes were associated with a higher risk of later cardiovascular events even after adjusting for traditional risk factors.

Why would a symptom of thermoregulation relate to arteries? Hot flashes reflect instability in the brain’s temperature center and in the autonomic nervous system, and they come with surges in sympathetic activity and brief spikes in blood pressure. Women with more flashes may simply have more reactive vascular systems. Another explanation is sleep: night sweats fragment sleep, and short or broken sleep independently raises blood pressure and blood sugar.

It is worth being precise about what this evidence is. It is observational. Hot flashes are a marker that travels with higher risk; no one has shown that the flashes themselves damage arteries, and treating flashes has not been shown in a randomized trial to lower heart attacks or strokes. The 2020 AHA statement calls vasomotor symptoms a potential marker of adverse cardiovascular health rather than a cause.

The practical reading is modest and useful. A woman with severe or long-lasting flashes has a reason to make sure her blood pressure, cholesterol and blood sugar are actually checked rather than assumed. Sleep apnea, which becomes far more common after menopause and often masquerades as night sweats and fatigue, deserves a specific question to her clinician.

Does early menopause raise heart risk?

Menopause before age 45 is considered early; before 40 it is called premature ovarian insufficiency. Both affect a meaningful minority of women, around one in twenty for early menopause and about one in a hundred for premature.

Across large pooled analyses, women who reached menopause before 45 had roughly a 50 percent higher relative risk of coronary heart disease than those reaching it at 50 or later, and the risk rose further the earlier menopause occurred. Surgical menopause, when both ovaries are removed before the natural age, shows a similar or larger association, particularly when no hormone therapy follows.

The intuitive explanation is more years of life without estrogen’s effect on vessels, cholesterol metabolism and fat distribution. That is probably part of it. A second explanation points the other way: the same inflammatory, metabolic or genetic factors that stress the ovaries early may also stress the heart, so early menopause could be a signal of underlying risk rather than purely its cause. Cohort studies that measured risk factors before menopause found that women with worse cardiovascular profiles in their thirties were more likely to reach menopause early, supporting both directions of influence.

Guidelines have absorbed this evidence. The 2018 US cholesterol guideline listed premature menopause among the “risk-enhancing factors” that can tip a decision toward statin therapy in a woman whose calculated risk is borderline. For women with premature ovarian insufficiency, professional societies generally support hormone therapy until the usual age of menopause, in the absence of contraindications, as replacement of what the body would normally make rather than as added treatment; the specifics are a decision for the treating clinician.

The message for a woman who stopped menstruating at 42 is not alarm. It is that her heart risk assessment should start earlier and be more thorough than her birth year alone would suggest.

What the evidence actually says

A useful way to read any health claim is to ask what kind of study stands behind it. Randomized controlled trials, where people are assigned by chance to a treatment or comparison, are the strongest. Observational cohorts, which follow people over years and record what happens, can show associations but not cause. Expert opinion fills the gaps. Here is how the main claims in this field stack up.

Blood pressure rises across the menopause transition. Supported by multiple large observational cohorts. The independent contribution of menopause, separate from age and weight, is modest and inconsistently found. Evidence grade: moderate for the association, low for an independent causal effect.

LDL cholesterol rises around the final menstrual period. Supported by repeated-measures cohort data showing a step change tied to menopause timing, plus a plausible receptor mechanism. Evidence grade: strong for the association; this is the best-established change.

Treating high blood pressure toward 130/80 reduces strokes and heart attacks in women. Supported by randomized trials that enrolled women, summarized in the 2025 guideline. Evidence grade: strong.

Hormone therapy protects the heart. Suggested by older observational studies, not confirmed in the Women’s Health Initiative randomized trials. Subgroup analyses hint at a neutral or favorable effect when started close to menopause, but subgroup findings are hypothesis-generating. Evidence grade: randomized evidence does not support using hormone therapy to prevent heart disease.

Hot flashes signal higher cardiovascular risk. Observational only. Evidence grade: moderate for association, none for causation or for treatment reducing events.

Early menopause raises heart risk. Consistent across many cohorts and meta-analyses, with some evidence of reverse causation. Evidence grade: moderate to strong for association.

Lifestyle changes lower blood pressure and LDL after menopause. Supported by randomized trials of diet, sodium reduction, exercise and weight loss, most of which included midlife women. Evidence grade: strong.

Does hormone therapy raise or lower blood pressure and cholesterol?

Menopausal hormone therapy means prescription estrogen, with a progestogen added for women who still have a uterus, used to treat symptoms such as hot flashes, night sweats and vaginal dryness. Because estrogen loss is tied to vascular changes, it is natural to ask whether replacing it reverses them. The randomized trial record gives a layered answer.

On cholesterol, oral estrogen lowers LDL and raises HDL, by amounts in the range of 10 to 15 percent in trials, through the same liver-receptor route that estrogen uses before menopause. It also raises triglycerides, which can be a problem for women whose triglycerides are already high. Estrogen delivered through the skin has smaller effects on all three, because it bypasses the first pass through the liver.

On blood pressure, the Women’s Health Initiative found a small average increase in systolic pressure, around one to two mmHg, in women taking oral combined therapy compared with placebo. Observational comparisons suggest skin patches and gels are closer to neutral. A minority of women experience a larger rise on oral therapy, which is why blood pressure is checked after starting and why controlled hypertension is listed as a reason for caution rather than an absolute bar.

On heart events, the question that matters most, the WHI trials did not show protection and showed harm in some groups, notably women who started therapy many years after menopause. Later analyses by age suggested a neutral effect in women under 60 or within ten years of menopause, which is the basis of the so-called timing hypothesis. Current guidance from cardiology and menopause societies agrees on the core point: hormone therapy is prescribed to treat symptoms, not to prevent cardiovascular disease.

Whether it is appropriate for an individual woman depends on her symptoms, her age, how long since menopause, her blood pressure and cholesterol, and her personal and family history. That weighing belongs with her prescribing clinician, and any change to an existing prescription should go through the same person.

Common myths about menopause and blood pressure

Viral health content thrives on simple claims. Several circulating ones about menopause and blood pressure deserve a correction.

“There is a 60-second trick that lowers blood pressure.” Slow, deep breathing for a minute can lower a reading by a few mmHg while you are doing it, because it dampens sympathetic tone. Device-guided slow breathing practiced daily for weeks has shown small sustained reductions in some trials. Neither is a treatment for hypertension, and using a breathing exercise to coax a better number right before a measurement hides the information a clinician needs.

“There are 50 symptoms of menopause and high blood pressure is one of them.” No medical body publishes a list of 50 symptoms. The NHS and other mainstream sources describe a core set: hot flashes, night sweats, sleep disturbance, mood changes, vaginal dryness, joint aches and brain fog among them. High blood pressure is not a symptom of menopause; it is a condition that becomes more common in the same years and usually produces no symptoms at all.

“Menopause means I will definitely get high blood pressure.” Most women do not have hypertension at menopause. The transition raises the odds over the following decade; it is not a sentence.

“Hormone therapy will fix my heart risk.” Randomized trials do not support that claim, as the previous section explains.

“Cholesterol is a man’s problem.” Heart disease is the leading cause of death in women in the United States, and LDL rises more sharply in women than in men during the fifties.

“If I feel fine, my blood pressure is fine.” Hypertension is nicknamed the silent condition for a reason. Headaches, dizziness or flushing are unreliable guides, and most women with stage 1 or stage 2 readings feel entirely well.

“A supplement can replace medication.” No supplement has randomized evidence comparable to prescription treatment for lowering blood pressure or LDL. Anyone considering a supplement should mention it to the clinician who manages their prescriptions.

How to check your blood pressure at home properly

The 2025 guideline put home readings at the heart of diagnosis, and for good reason: they predict heart risk better than office readings and they catch both the white-coat and masked patterns. Technique is where most home readings go wrong.

Choose a validated upper-arm cuff monitor rather than a wrist or finger device; the American Heart Association maintains lists of validated models. Make sure the cuff fits. A cuff that is too small reads falsely high, and this error is common in women with larger upper arms.

Before measuring, skip caffeine, exercise and smoking for 30 minutes, empty your bladder, and sit quietly for five minutes. Sit in a chair with your back supported, feet flat on the floor, legs uncrossed, and your arm resting on a table so the cuff is at heart level. Do not talk during the reading. Take two readings a minute apart and record both; many monitors average them automatically.

A typical monitoring plan is two readings in the morning before medication or breakfast and two in the evening, for seven days, then discarding the first day. The average of the remaining readings is what a clinician will use. Home averages run slightly lower than office readings, and the guideline treats a home average of 130/80 as equivalent to an office reading in that range.

Keep a simple log with the date, time and any notes about sleep or a hot flash. A single high number is information, not a verdict; a pattern is what matters. Bring the monitor to an appointment once a year so it can be checked against the clinic’s device.

One more habit helps: do not measure during or right after a hot flash. The autonomic surge that accompanies a flash can push a reading up transiently and muddy the average you are trying to build.

What lowers blood pressure and cholesterol after menopause?

The levers that work at 55 are the same ones that work at 35, and randomized trials have measured how much each one moves the numbers. The 2025 guideline summarizes them.

Sodium is the single biggest dietary factor. The guideline sets a limit of 2,300 mg a day with an ideal target closer to 1,500 mg, and notes that most sodium comes from packaged and restaurant food rather than the shaker. Cutting intake by about a third lowers systolic pressure by roughly 5 to 6 mmHg in people with hypertension. Potassium-rich foods such as beans, leafy greens, yogurt and bananas help, and the guideline mentions potassium-enriched salt substitutes for people without kidney disease, a decision to run past a clinician because of interactions with some medicines.

The DASH eating pattern, built on vegetables, fruit, whole grains, nuts and low-fat dairy, lowered systolic pressure by about 11 mmHg in people with hypertension in its original trial, and it also lowers LDL. A Mediterranean-style diet has comparable support for cholesterol and for heart events.

Physical activity of 75 to 150 minutes a week, mixing brisk walking with two sessions of resistance training, lowers systolic pressure by around 5 to 8 mmHg and is especially effective at trimming visceral fat. Weight loss of about five percent of body weight produces a further drop.

Alcohol raises blood pressure in a dose-dependent way. The guideline’s advice, abstain if possible and otherwise no more than one drink a day for women, reflects trial data showing that cutting intake lowers pressure within weeks.

Sleep deserves equal billing. Treating sleep apnea and protecting seven or more hours a night both improve blood pressure control.

When lifestyle changes are not enough, medication is not a failure. Blood pressure medicines and statins have decades of randomized evidence in women. Which drug, at what strength, and when to start are decisions for the prescribing clinician based on the whole picture, including kidney function, other conditions and the woman’s own preferences.

When to see a doctor

A blood pressure reading rarely needs an emergency room on its own, and knowing the difference between “book an appointment” and “go now” saves a great deal of anxiety.

A reading of 140 over 90 with no symptoms is stage 2 high blood pressure and warrants a visit to your clinician within the next week or two, not a trip to the hospital. Sit quietly for five minutes, recheck, and if the number holds, start a home log and make the appointment. The same applies to a first-time stage 1 reading: confirm it at home over a week, then discuss it.

Seek emergency care immediately, by calling emergency services, if a reading is above 180 systolic or above 120 diastolic and does not come down after five minutes of rest, or if any high reading comes with chest pain or pressure, shortness of breath, sudden weakness or numbness on one side, trouble speaking, confusion, a sudden severe headache unlike any before, vision loss or blurring, or severe back pain. These can be signs of a stroke, heart attack, aortic tear or hypertensive emergency, and minutes matter.

Beyond the numbers, make an appointment if you are in the menopause transition and have not had blood pressure, a lipid panel and a blood sugar check in the past year; if your periods stopped before 45; if you have frequent or severe hot flashes or night sweats that disrupt sleep; if you snore loudly or wake unrefreshed; if you have a parent or sibling who had heart disease before 60; or if you had high blood pressure or diabetes during a pregnancy, which independently raises later heart risk.

Bring your home readings and any medicines or supplements you take, including hormone therapy. If you are already prescribed a blood pressure medicine, a statin or hormone therapy, do not stop or change it on your own because of something you read online. Raise the question with the clinician who prescribed it; they can weigh new evidence against your history in a way no article can.

Frequently asked questions

What is a normal blood pressure for a woman in her 50s?

Below 120 over 80 mmHg is normal at any adult age, including the fifties. Readings of 120 to 129 systolic with a diastolic under 80 are classed as elevated, 130 to 139 or 80 to 89 is stage 1 high blood pressure, and 140 or 90 and above is stage 2. Diagnosis rests on the average of several readings taken on different days, ideally at home with a validated upper-arm cuff.

Does menopause cause high blood pressure?

Not directly, but it raises the odds. Falling estrogen stiffens arteries slightly, encourages sodium retention and shifts fat toward the abdomen, while aging stiffens arteries further. Large cohort studies show blood pressure rising across the transition, with most of the increase explained by age and weight and a modest additional effect attributable to menopause itself. The result is that women overtake men in hypertension rates in the decade after 50.

How does menopause and cholesterol change relate to heart risk?

LDL cholesterol climbs sharply around the final menstrual period, by about 10 percent in the Study of Women’s Health Across the Nation, because lower estrogen means fewer LDL receptors on the liver. Higher LDL over years deposits cholesterol in artery walls and raises the risk of heart attack and stroke. A lipid panel in the year after periods stop, and every four to six years or more often thereafter, is standard advice.

What is the 60 second trick to lower blood pressure?

There is no trick that treats high blood pressure in a minute. Slow, deep breathing for 60 seconds can transiently drop a reading by a few mmHg by calming the sympathetic nervous system, and daily device-guided breathing has shown small sustained effects in some trials. Doing it right before a measurement produces a misleadingly low number. Lasting control comes from sodium reduction, activity, weight, sleep, alcohol limits and, where needed, medication prescribed by a clinician.

Should I go to the hospital if my blood pressure is 140 over 90?

Not for that number alone. A reading of 140 over 90 without symptoms is stage 2 high blood pressure and needs a clinician appointment within a week or two, plus a week of home readings to bring along. Go to the emergency department or call emergency services if a reading is above 180 over 120 and stays there after five minutes of rest, or if any high reading comes with chest pain, breathlessness, weakness, confusion, vision change or a sudden severe headache.

What are 50 common symptoms of menopause?

No medical body publishes a list of 50 symptoms; that figure comes from viral posts, not clinical sources. Mainstream guidance such as the NHS describes a core set: hot flashes, night sweats, sleep disturbance, mood changes, difficulty concentrating, vaginal dryness, lower libido, joint aches and headaches, among others. High blood pressure is not a symptom of menopause. It is a separate, usually symptomless condition that becomes more common in the same years.

Do hot flashes mean I have heart problems?

Hot flashes are a marker, not a diagnosis. Observational studies link frequent or long-lasting hot flashes with thicker artery walls and a somewhat higher later risk of cardiovascular events, possibly through autonomic reactivity and broken sleep. No trial has shown that the flashes themselves damage arteries or that treating them prevents heart disease. Severe flashes are a reasonable prompt to have blood pressure, cholesterol and blood sugar actually measured.

Does hormone therapy raise blood pressure?

On average, slightly. In the Women’s Health Initiative, oral combined hormone therapy raised systolic pressure by about one to two mmHg compared with placebo, and a minority of women see a larger rise. Estrogen through the skin appears closer to neutral in observational comparisons. Controlled high blood pressure is a reason for monitoring rather than an absolute bar, and whether therapy is appropriate is a decision for the prescribing clinician.

Does early menopause increase heart disease risk?

Yes, in observational data. Women who reach menopause before 45 show roughly a 50 percent higher relative risk of coronary heart disease than those reaching it at 50 or later, with higher risk the earlier it occurs, and surgical menopause shows a similar pattern. Part of the link may run the other way, with early vascular risk factors hastening ovarian aging. Premature menopause is listed as a risk-enhancing factor in US cholesterol guidelines.

How often should women over 50 check blood pressure and cholesterol?

Blood pressure at least once a year if it is normal, and more often, including a home monitoring week, if it has ever been elevated or high. Cholesterol every four to six years at average risk, with a lipid panel in the year after menopause and more frequent checks if results are borderline, there is a family history, or menopause came before 45. A clinician may also add a blood sugar check and a kidney function test to calculate ten-year risk.

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.